InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by FRATES JAMES M, Director. Director active across 1 companies, notably Sage Therapeutics, Inc.. Aggregated, 2 reports have been published. Total volume traded: €166k. The latest transaction was disclosed on 16 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
1,810 shares@ €45.9352100.0% of flowCommon StockSEC:0001562180-21-004347
Ideal exit: 13 Mar 2022 (T+270)
1,810 shares@ €45.935250.0% of flowCommon StockSEC:0001562180-21-004347:0
Ideal exit: 13 Mar 2022 (T+270)
2 of 2 declarations
About FRATES JAMES M
James M. Frates is a Board Member at Sage Therapeutics, Inc. He plays a vital role in overseeing the company's activities and strategic direction. With extensive experience in the healthcare sector, he contributes to policy development that fosters innovation and efficiency. His commitment to the company's mission is crucial for its growth and success.
